These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 32772131)
21. Could systemic immune inflammation index be a new parameter for diagnosis and disease activity assessment in systemic lupus erythematosus? Ozdemir A; Baran E; Kutu M; Celik S; Yılmaz M Int Urol Nephrol; 2023 Jan; 55(1):211-216. PubMed ID: 35918626 [TBL] [Abstract][Full Text] [Related]
22. Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis. Yayla ME; İlgen U; Okatan İE; UsluYurteri E; Torgutalp M; Keleşoğlu Dinçer AB; Aydemir Gülöksüz EG; Sezer S; Turgay TM; Kınıklı G; Ateş A Clin Rheumatol; 2020 Jan; 39(1):77-83. PubMed ID: 31317426 [TBL] [Abstract][Full Text] [Related]
23. Value of SLE-DAS in assessing disease activity in patients with systemic lupus erythematosus: a single-centre retrospective study. Ma J; Zhang L; Yan M; Liu Z; Xue L Lupus Sci Med; 2024 Jun; 11(1):. PubMed ID: 38862157 [TBL] [Abstract][Full Text] [Related]
24. Hematological indices as indicators of silent inflammation in achalasia patients: A cross-sectional study. López-Verdugo F; Furuzawa-Carballeda J; Romero-Hernández F; Coss-Adame E; Valdovinos MA; Priego-Ranero A; Olvera-Prado H; Narváez-Chavez S; Peralta-Figueroa J; Torres-Villalobos G Medicine (Baltimore); 2020 Feb; 99(9):e19326. PubMed ID: 32118763 [TBL] [Abstract][Full Text] [Related]
25. Assessment of hematologic indices for diagnosis in juvenile systemic lupus erythematosus. Baykal GÖ; Vazgeçer EO; Sözeri B Reumatologia; 2024; 62(2):74-82. PubMed ID: 38799776 [TBL] [Abstract][Full Text] [Related]
26. The presumable effects of hydroxychloroquine and its metabolites in the treatment of systemic lupus erythematosus. Pan M; Jin R; Dai Y; Gao B; Liu Y; Peng X; Qiao J; Shuai Z Int Immunopharmacol; 2024 Jan; 126():111269. PubMed ID: 38006753 [TBL] [Abstract][Full Text] [Related]
28. A potential biomarker of disease activity in systemic lupus erythematosus, systemic immune-inflammation index. Akdogan MR; Melikoglu MA North Clin Istanb; 2024; 11(2):115-119. PubMed ID: 38757099 [TBL] [Abstract][Full Text] [Related]
29. Role of NLR, PLR, ELR and CLR in differentiating COVID-19 patients with and without pneumonia. Damar Çakırca T; Torun A; Çakırca G; Portakal RD Int J Clin Pract; 2021 Nov; 75(11):e14781. PubMed ID: 34482573 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in pregnant women with systemic lupus erythematosus. Ekici H; Imamoglu M; Okmen F; Gencosman G; Ak G; Ergenoglu M J Obstet Gynaecol; 2022 Jul; 42(5):872-876. PubMed ID: 34565265 [TBL] [Abstract][Full Text] [Related]
32. Initial hydroxychloroquine monotherapy in systemic lupus erythematosus: report of three cases. Ichikawa K; Kirino Y; Kunishita Y; Kishimoto D; Takase-Minegishi K; Yoshimi R; Nakajima H Mod Rheumatol Case Rep; 2021 Jul; 5(2):259-264. PubMed ID: 33533686 [TBL] [Abstract][Full Text] [Related]
33. Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus. Penn SK; Kao AH; Schott LL; Elliott JR; Toledo FG; Kuller L; Manzi S; Wasko MC J Rheumatol; 2010 Jun; 37(6):1136-42. PubMed ID: 20436082 [TBL] [Abstract][Full Text] [Related]
34. The C-Reactive Protein/Albumin Ratio and Complete Blood Count Parameters as Indicators of Disease Activity in Patients with Takayasu Arteritis. Seringec Akkececi N; Yildirim Cetin G; Gogebakan H; Acipayam C Med Sci Monit; 2019 Feb; 25():1401-1409. PubMed ID: 30792377 [TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of blood parameters for community-acquired pneumonia. Huang Y; Liu A; Liang L; Jiang J; Luo H; Deng W; Lin G; Wu M; Li T; Jiang Y Int Immunopharmacol; 2018 Nov; 64():10-15. PubMed ID: 30144639 [TBL] [Abstract][Full Text] [Related]
36. Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort. Geraldino-Pardilla L; Perel-Winkler A; Miceli J; Neville K; Danias G; Nguyen S; Dervieux T; Kapoor T; Giles J; Askanase A Lupus; 2019 Jun; 28(7):862-867. PubMed ID: 31122136 [TBL] [Abstract][Full Text] [Related]
37. [Incidence of metabolic syndrome in systemic lupus erythematosus and its influence by glucocorticoids]. Liu SY; Guo JY; Zhang L; Liu ZS; Zheng ZH; Cheng GY; Gao GM; Zhang X; Liu GZ; Zeng XF Zhonghua Nei Ke Za Zhi; 2012 Jun; 51(6):441-4. PubMed ID: 22943753 [TBL] [Abstract][Full Text] [Related]
38. Red blood cell distribution width is a potential index to assess the disease activity of systemic lupus erythematosus. Hu ZD; Chen Y; Zhang L; Sun Y; Huang YL; Wang QQ; Xu YL; Chen SX; Qin Q; Deng AM Clin Chim Acta; 2013 Oct; 425():202-5. PubMed ID: 23954839 [TBL] [Abstract][Full Text] [Related]
39. Burden of systemic lupus erythematosus in clinical practice: baseline data from the SLE Prospective Observational Cohort Study (SPOCS) by interferon gene signature. Arnaud L; Furie R; Morand EF; Aringer M; Peschken C; Desta B; Rapsomaniki E; Hedberg J; Knagenhjelm J; Seo C; Grünfeld Eén T; Sorrentino A; Tummala R; Stirnadel-Farrant HA; Ding B Lupus Sci Med; 2023 Dec; 10(2):. PubMed ID: 38123459 [TBL] [Abstract][Full Text] [Related]
40. Prognostic nutritional index is correlated with disease activity in patients with systemic lupus erythematosus. Ahn SS; Jung SM; Song JJ; Park YB; Lee SW Lupus; 2018 Sep; 27(10):1697-1705. PubMed ID: 30020022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]